Regulatory Open Forum

 View Only
  • 1.  Annotated USPI

    Posted 31-Mar-2022 12:16
    Hi,
    I was wondering if there is a specific format preferred by FDA to submit annotated USPI.
    I have seen a lot of variability in the ways annotated USPI is submitted across different companies, so wanted to understand what exactly is required by the FDA. I am not finding any specific guidance explaining this.
    Any help is appreciated,
    Thanks,
    Kamana


  • 2.  RE: Annotated USPI

    Posted 01-Apr-2022 08:13
    Hi Kamana,

    I also have not seen FDA define a format. I don't think the format matters as long as such a document is included in the submission. I have always used a two-column table format with the PI text on the left and the annotations on the right. That has been my practice for 30 years and FDA has never complained.

    ------------------------------
    Glen Park PharmD
    Vice President, Regulatory Affairs and Quality Assurance
    New York NY
    United States
    ------------------------------



  • 3.  RE: Annotated USPI

    Posted 01-Apr-2022 13:58
    Thanks Glen, 
    I like the idea of having annotations in a separate column. I am assuming that you first develop the USPI and then create a separate  document with the added column for annotations, as it has to be annotated to the summary documents that are finalized later in the process.
    Thanks,
    Kamana





  • 4.  RE: Annotated USPI

    This message was posted by a user wishing to remain anonymous
    Posted 04-Apr-2022 09:45
    This message was posted by a user wishing to remain anonymous

    I much prefer the two column approach Glen mentions but it seems like there is a shift to using MS Word Comment bubbles; last half dozen new labels I've seen have taken this route.


  • 5.  RE: Annotated USPI

    Posted 05-Apr-2022 11:17
    Dear Kamana,

    Submission of the proposed text of the label as a clean copy and as a marked up or track changes versions facilitates timely review and discussion of counter proposed or edited language.  In my personal experience,  annotated USPI submitted in MS-word with track changes "all markup" and "show revisions in balloons" (on the right side) enabled helps the review team identify each proposed change and provide a way to "reply" and communicate the Agency's agreement/s or request/s for additional content and format edits as needed, but this is not a requirement.  You may want to perform a quality check before filing your annotated USPI using the "Selected Requirements of Prescribing Information (SRPI)" checklist available at https://www.fda.gov/media/87094/download

    ------------------------------
    Juliane Carvalho RAC, MSc
    Lead Regulatory Health Project Manager
    United States
    **My comments are an informal communication and represent my own best judgement. These comments do not necessarily represent the postings, strategies, opinions, legal advice of the U.S. Food and Drug Administration**
    ------------------------------